NASDAQ:SRPT   Sarepta Therapeutics, Inc.
This stock had a stock split without splitting it split about 50% due to bad earnings...it has now found support on the 200 dma. This offers a good entry should you take the risk to buy here. However it may be best to wait until it breaks out to the upside or downside to take a trade long/short. The potential on breakout to upside is back to the 40s could take months but would be a double from here,

면책사항

이 정보와 게시물은 TradingView에서 제공하거나 보증하는 금융, 투자, 거래 또는 기타 유형의 조언이나 권고 사항을 의미하거나 구성하지 않습니다. 자세한 내용은 이용 약관을 참고하세요.